MRTX Stock News 16.35 05/13/2014 04:35:25 Mirati Therapeutics

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Mirati Therapeutics Inc (MRTX) 16.35 $MRTX

Charles M. Baum, M.D., PH.D. Joins Array BioPharma Board Of Directors
PR Newswire - Mon Apr 28, 3:00PM CDT
Array BioPharma Inc. (NASDAQ: ARRY) today announced that as part of its continued evolution toward late-stage development and commercialization, Charles M. Baum, M.D., Ph.D., President and Chief Executive Officer of Mirati Therapeutics, joined the company's board of directors, effective April 25, 2014.

Launch of Additional First- and Second-Line Options Will Substantially Expand the Treatment Landscape for Myelodysplastic Syndromes Through 2023
PR Newswire - Thu Apr 03, 10:00AM CDT
Decision Resources Group finds that azacitidine (Celgene's Vidaza, generics) will continue to be the patient share leader in treatment of myelodysplastic syndromes (MDS) in the United States and major European markets during the 2013-2023 study period. According to clinical trial data and expert opinion, treatment options for MDS will expand significantly over the next decade with the launches of as many as five novel therapies: Cyclacel's sapacitabine, Mirati Therapeutics' mocetinostat, Celgene's oral azacitidine, Onconova's oral rigosertib and Acceleron/Celgene's sotatercept, as well as a label extension for GlaxoSmithKline's Revolade/Promacta.

Nasdaq stocks posting largest percentage decreases
AP - Mon Mar 24, 2:40PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage decliners on Nasdaq at 1 p.m.:

William R. Ringo Joins Mirati Board of Directors
PR Newswire - Thu Mar 20, 7:00AM CDT
Mirati Therapeutics, Inc. (NASDAQ: MRTX) today announced that biotechnology industry veteran William Ringo has joined its board of directors.

Mirati Therapeutics Reports Fourth Quarter and Full Year 2013 Financial Results
PR Newswire - Mon Mar 17, 3:01PM CDT
Mirati Therapeutics, Inc. ("Mirati" (NASDAQ: MRTX) today reported financial results for the fourth quarter and year ended December 31, 2013 and provided a corporate update.

2 Biotech Stocks Rising on Big Volume
at The Street - Tue Feb 25, 5:00AM CST
Keep these biotech stocks trading on unusual volume on your radar.

Mirati Therapeutics to Present at the 2014 Leerink Global Healthcare Conference
PR Newswire - Wed Feb 05, 7:00AM CST
Mirati Therapeutics, Inc. (NASDAQ: MRTX) today announced that the company will present at the 2014 Leerink Global Healthcare Conference on Thursday, February 13 at 1:00 PM Eastern Time in New York.

Mirati Presents Clinical Response Results of Mocetinostat in Combination with Azacitidine as a Treatment for MDS
PR Newswire - Mon Dec 09, 9:10AM CST
Mirati Therapeutics, Inc. ("Mirati" (NASDAQ: MRTX) today presented data at the 2013 American Society of Hematology (ASH) Annual Meeting demonstrating promising clinical response rates in patients with myelodysplastic syndromes (MDS) patients treated with mocetinostat in combination with azacitidine. Separately, Mirati announced that it has dosed the first patients in its Phase 2 dose confirmation trial of mocetinostat in combination with azacitidine for the treatment of MDS.

Updated Presentation Time: Mirati Therapeutics to Present at the 25th Annual Piper Jaffray Healthcare Conference
PR Newswire - Mon Dec 02, 7:00AM CST
Mirati Therapeutics, Inc. (NASDAQ: MRTX) today announced that the company will present at the 25th Annual Piper Jaffray Healthcare Conference on Wednesday, December 4, 2013 at 10:30 AM Eastern Time in New York.

Mirati Therapeutics to Present at the 25th Annual Piper Jaffray Healthcare Conference
PR Newswire - Fri Nov 22, 7:00AM CST
Mirati Therapeutics, Inc. (NASDAQ: MRTX) today announced that the company will present at the 25th Annual Piper Jaffray Healthcare Conference on Wednesday, December 4, 2013 at 4:00 PM Eastern Time in New York.

Mirati Therapeutics Reports Third Quarter 2013 Financial Results
PR Newswire - Tue Nov 12, 7:00AM CST
Mirati Therapeutics, Inc. ("Mirati" (NASDAQ: MRTX) today reported financial results for the third quarter and nine months ended September 30, 2013.

Mirati Therapeutics Appoints Isan Chen as Chief Medical and Development Officer and Adds Craig Johnson to Board of Directors
Marketwire - Wed Sep 04, 5:31AM CDT
Mirati Therapeutics (NASDAQ: MRTX) today announced the appointment of Isan Chen, M.D., as chief medical and development officer as well as the appointment of Craig Johnson to its board of directors and as the chairman of the audit committee.

Mirati Therapeutics Reports Second Quarter 2013 Financial Results
Marketwire - Mon Aug 12, 5:31AM CDT
Mirati Therapeutics, Inc. ("Mirati" (NASDAQ: MRTX) today reported financial results for the second quarter and first six months ended June 30, 2013.

Mirati Therapeutics to Voluntarily Delist from TSX
Marketwire - Fri Jul 19, 3:22PM CDT
Mirati Therapeutics Inc. (TSX: MYG)(NASDAQ: MRTX) ("Mirati Therapeutics" today announced that, consistent with its previously disclosed plans, it has applied to the Toronto Stock Exchange ("TSX" to voluntarily delist from trading its shares of common stock. Effective at market close on July 26, 2013, Mirati's common stock will no longer be traded through the facilities of the TSX. Mirati's shares of common stock are currently traded, and will continue to be traded, on the NASDAQ Capital Market ("NASDAQ", under the ticker symbol "MRTX".

LifeSci Advisors Initiates Coverage of Mirati Therapeutics
Marketwire - Thu Jul 18, 8:02AM CDT
LifeSci Advisors, LLC (NASDAQ: MRTX) (TSX: MYG)

Mirati Therapeutics to Commence Trading on the NASDAQ
Marketwire - Mon Jul 15, 7:15AM CDT
Mirati Therapeutics Inc. ("Mirati Therapeutics" or the "Company" (TSX: MYG) (NASDAQ: MRTX) today announced that the NASDAQ Capital Market ("NASDAQ" has informed the Company that its common stock will commence trading on the NASDAQ beginning today, July 15, 2013 under the ticker symbol MRTX.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

ROKFORM’s Signal Card: A Wallet Tracker for All

Updated Category News Views 4

The Gadget You Didn't Know You Needed Ever feel that momentary panic when your wallet seems to have vanished into thin air? ROKFORM's fresh offering, the Signal Card, tackles that heart-stopping moment head-on. They've taken the mundane act of misplacing your wallet and transformed it with their sleek, credit-card-sized tracker. This baby pairs seamlessly with Apple Find...

Continue Reading
Epic Political Thriller Explores Humanity's Future

Updated Category News Views 3

Adams' Provocative Debut Asks Timeless Questions Sometimes life throws a philosophical curveball, and that's exactly what John C. Adams has done with his debut novel, The Third Phase. This isn't your average political yarn—it's an intricate tapestry intertwining political intrigue, deep spiritual inquiry, and hearty doses of classic philosophy. A Whirlwind Journey...

Continue Reading
Truss Financial Tackles Home Equity Closing Delays

Updated Category News Views 5

Truss Financial Group's Bold Move Against Closing Delays In real estate, time is money. Even the most casual market observer could tell you delays can slice through a deal like a hot knife through butter. That's the headache home equity borrowers face, blindsided by closing delays that sneak up on them without warning. An Industry Bottleneck Finally Addressed Enter Truss...

Continue Reading
Cure Blindness Project's 770K Screenings for World Sight Day

Updated Category News Views 5

Visionary Steps Toward a Brighter Future No two words could describe the task that Cure Blindness Project is tackling this year: vision and action. Marking World Sight Day on October 8, they plan to usher in 770,000 eye screenings across Asia, Africa, and the Caribbean. These initiatives aren't just numbers—they're a colossal step toward lifting the veil of avoidable...

Continue Reading
Pushing for National Liver Cancer Awareness in 2026

Updated Category News Views 4

The Urgency of Liver Cancer Awareness Death doesn’t wait, does it? When liver cancer is the villain in question, every moment becomes precious because this beast doesn’t roar until it’s too late. Here we are in 2026, staring at nearly 31,000 annual deaths in the U.S. alone. But hope flickers with a new congressional resolution aiming to slap a bright spotlight on...

Continue Reading
Skandia's Soundproofing Kit Expands to Brazil's Skies

Updated Category News Views 3

Soundproofing Takes Off in Brazil Skandia has just pulled off a neat trick, earning the nod from Brazil's National Civil Aviation Agency (ANAC) for their King Air soundproofing kit. That means quieter skies ahead for operators of the King Air 200 and 300 series in Brazil. This is no small feat, folks; it's like finally getting that coveted backstage pass after years of...

Continue Reading
Bob Evans' Protein Mac & Cheese: Practical Power Play

Updated Category News Views 13

Has anyone else noticed just how fast the world spins when it comes to consumer trends these days? Bob Evans is hopping right on the protein bandwagon with its latest launch, a microwave-ready Protein Macaroni & Cheese that packs 18 grams of protein per serving. You gotta hand it to them for seizing opportunity when they see it. This one's not just about tossing a new...

Continue Reading
Charter Next Generation Unveils Gen 2 MDO-PE Films

Updated Category News Views 5

Peering Into CNG's Latest Innovation Charter Next Generation (CNG) just threw down a hefty gauntlet with its launch of next-gen machine-direction-oriented polyethylene (MDO-PE) solutions. They're pushing the envelope on what recycle-ready packaging can do, folks. Let's not mince words—other players in the field better have their game faces on. This ain't just another...

Continue Reading
Purina Institute Highlights Nutritional Science at WSAVA 2026

Updated Category News Views 7

A Global Stage for Pet Nutrition Science The folks over at the Purina Institute are back in the spotlight as they gear up to throw their weight behind the 51st World Small Animal Veterinary Association (WSAVA) Congress in Warsaw, Poland. Set for October 13-15, 2026, this isn’t just another event—they're bringing some serious clout with their 'Food for Thought'...

Continue Reading
TA Services Strengthens U.S.-Mexico Freight Operations

Updated Category News Views 3

TA Services Moves Boldly Across Borders If ever there was a time to play the logistics chessboard like a champ, it's now, and TA Services just slammed the board with a solid move. They've grabbed Carmen Pacheco Transportation and Interload Forwarding, two family-run operations with some real muscle in North American logistics. This isn't a small-time maneuver; they've...

Continue Reading

Top 5 Most Recently Viewed Articles

Insights on U.S. Retail Growth: Holiday Spending Trends

Updated Category News Views 369

Key Insights into U.S. Retail Growth This Holiday Season The recent data from Mastercard SpendingPulse reveals fascinating insights about U.S. retail sales performance during the holiday season. Despite a challenging economic backdrop, preliminary insights show that total retail sales increased by 3.8% year-over-year, indicating a resilient consumer spending power between...

Continue Reading
Engaging Story Behind the Latest Innovations by MultiVu

Updated Category News Views 215

Unveiling the Latest Innovations from MultiVu In the fast-paced digital marketing world, it is essential to stay ahead of the curve. MultiVu has stepped up to the plate, revealing a plethora of innovations that are set to transform the way businesses connect with their audiences. These developments are tailored to enhance engagement, efficiency, and accessibility,...

Continue Reading
The Joint Chiropractic Unveils Innovative Mobile App for Patients

Updated Category News Views 125

The Joint Chiropractic Unveils Innovative Mobile App for Patients – New App Brings Convenient Features to Patients – Today, The Joint Corp. (NASDAQ: JYNT), the nation's largest franchisor of chiropractic care through The Joint Chiropractic network, proudly announces the launch of its new mobile app. This app is now available for download in popular app stores,...

Continue Reading
MBX Biosciences Reaches Key Milestone in Phase 1 Trial Progress

Updated Category News Views 76

MBX Biosciences Marks a Significant Milestone in Clinical Trials MBX Biosciences, Inc. (NASDAQ: MBX), a company dedicated to revolutionizing peptide therapies for endocrine and metabolic disorders, has announced a significant milestone in its clinical research. The last subject’s final visit has been completed in the Phase 1 trial of their investigational drug MBX 1416,...

Continue Reading
1440 Foods Enhances Active Nutrition with FITCRUNCH Acquisition

Updated Category News Views 139

1440 Foods Expands Portfolio with FITCRUNCH Acquisition 1440 Foods, a prominent name in the sports and active nutrition sector, has made headlines by acquiring FITCRUNCH, a popular protein bar brand founded by celebrity chef Robert Irvine. This collaboration marks an exciting chapter for both companies as they combine their strengths to offer superior nutrition products....

Continue Reading